INTERNATIONAL GROUP OF ENDOVASCULAR ONCOLOGY (IGEVO)

• IGEVO is a working group devoted to Hepatic Intra Arterial Chemotherapy (IAHC) and TACE
• IGEVO programs are oriented to treat liver metastases from ColoRectal Cancer, Ocular Melanoma, Neuroendocrine tumours, HCC, Colangiocarcinoma and intra Arterıal chemotherapy in melanoma/sarcoma relapsed to the limbs
• IGEVO is open to whom wants work, no inscription or any fee is due.

     OUR PLANS

IGEVO is starting now with 5 studies:

Liver mets from CRC:

• TACETUX ( DEBIRI PLUS CETUXIMAB)
• PANDEBIRI ( DEBIRI PLUS PANITUMAB) 

Hepatocellular Carcinoma

• DEBDOX plus Sorafenib

Liver mets from Ocular Melanoma

• DEBIRI

Melanoma and sarcoma relapses

Isolated Lımb cısplatın Infusıon